Ipsen to cut primary care sales force as French reforms bite
This article was originally published in Scrip
Executive Summary
French pharmaceutical company Ipsen says it will likely lay off around 100 of its primary care sales team in France during the first half of next year following a strong decline in sales of its primary care products and a failure to find a partner for the business. The downturn is a consequence of continued measures being untaken by the country's new socialist government as it attempts to balance its healthcare books.